In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025

体外診断用医薬品(IVD)の世界市場予測(~2025):製品・サービス別、技術別、用途別、エンドユーザー別

◆タイトル:In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025
◆商品コード:MD 3609
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年11月30日
◆ページ数:351
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は体外診断用医薬品(IVD)の世界市場が2020年845億ドルから2025年960億ドルまで、年平均2.6%成長すると予想しています。本市場調査資料では、体外診断用医薬品(IVD)の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業動向、製品・サービス別(試薬・キット、機器、サービス、データ管理ソフトウェア)分析、技術別(イムノアッセイ/免疫化学、臨床化学、分子診断、血液、微生物)分析、用途別(感染症、糖尿病、腫瘍、循環器、薬物検査/薬理ゲノミクス)分析、エンドユーザー別(病院研究所、臨床検査室、ポイントオブケア検査(POCT)、患者自己検査、学術機関)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業動向
・体外診断用医薬品(IVD)の世界市場規模:製品・サービス別(試薬・キット、機器、サービス、データ管理ソフトウェア)
・体外診断用医薬品(IVD)の世界市場規模:技術別(イムノアッセイ/免疫化学、臨床化学、分子診断、血液、微生物)
・体外診断用医薬品(IVD)の世界市場規模:用途別(感染症、糖尿病、腫瘍、循環器、薬物検査/薬理ゲノミクス)
・体外診断用医薬品(IVD)の世界市場規模:エンドユーザー別(病院研究所、臨床検査室、ポイントオブケア検査(POCT)、患者自己検査、学術機関)
・体外診断用医薬品(IVD)の世界市場規模:地域別
・競争状況
・企業情報

“The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period.”
Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices.

“By technology, within the IVD market, immunoassays segment holds the largest share in the forecast period.”
Based on technology, the in vitro diagnostics market has been segmented into immunoassays, clinical chemistry, molecular diagnostics, microbiology, hematology, urinalysis, coagulation and others. Immunoassays accounted for the largest share of the market in 2019. Significant market share can be associated with increasing investments of leading players such as Roche Diagnostics, Danaher Corporation, Abbott Laboratories, and others in developing superior quality immunoassays. These immunoassays are highly reliable and provide healthcare professionals with an accurate diagnosis that positively impacts the segmental growth.

“By application, the oncology segment is expected to grow at the fastest rate during the forecast period (2020-2025).”
Based on application, the in vitro diagnostics market has been segmented into infectious disease, oncology, diabetes, cardiology, drug testing, HIV/AIDS, auto-immune diseases, nephrology and others. The oncology segment is predicted to have higher growth rate as compared to other applications due to increasing prevalence of cancer in developed as well as developing countries. According to WHO, cancer is the second leading cause of death and there is an exponential increase in the number of cancer cases since past few years. This scenario proves beneficial for the segment growth as it increases the demand for efficient diagnostic tests, thereby, surging the overall industry growth.

“North America to hold the largest share.”
North America is expected to account for the largest share of the global in vitro diagnostics market in 2019. The large share of this region can primarily be attributed to the presence of a well-established base of IVD companies, high investments in the IVD devices and software, and increasing R&D expenditure. On the other hand, the APAC is expected to witness the highest CAGR during the forecast period due to the large number of research activities, low cost of operations in APAC countries, and large elderly population base.

The breakdown of primary participants is mentioned below:
• By Company Type: Tier 1–30%, Tier 2–45%, and Tier 3–25%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–35%, Europe–30%, the Asia Pacific–15%, Latin America–10%, Middle East & Africa – 10%

Research Coverage:
The report analyzes the various in vitro diagnostics products and their adoption patterns in different appliactions. It aims at estimating the market size and future growth potential of the global in vitro diagnostics market for different segments such as by products and services, technology, application, end-users and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro diagnostics market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro diagnostics market
• Market Development: Comprehensive information on lucrative emerging regions, by products and services, application, technology, end-users.
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global in vitro diagnostics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the global in vitro diagnostics market

【レポートの目次】

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.3 MARKET SCOPE 35
1.3.1 INCLUSIONS AND EXCLUSIONS 35
1.4 MARKETS COVERED 36
1.5 YEARS CONSIDERED FOR THE STUDY 36
1.6 CURRENCY 37
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 37
1.7 LIMITATIONS 37
1.8 STAKEHOLDERS 37
1.9 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
2.1.1 RESEARCH DESIGN 39
2.1.2 SECONDARY RESEARCH 40
2.1.2.1 Key data from secondary sources 41
2.1.3 PRIMARY RESEARCH 41
2.1.4 PRIMARY SOURCES 41
2.1.4.1 Key data from primary sources 43
2.1.4.2 Breakdown of Primaries 43
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 3 SUPPLY SIDE ANALYSIS: IVD MARKET (2019) 45
FIGURE 4 DEMAND SIDE APPROACH: RAPID TEST MARKET SIZE (2019) 46
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF MARKET DRIVERS, RESTRAINTS< OPPORTUNITIES & CHALLENGES OF THE IVD
INDUSTRY (2019-2025) 48
2.6 COVID-19 HEALTH ASSESSMENT 50
2.7 COVID-19 ECONOMIC ASSESSMENT 51
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 51
3 EXECUTIVE SUMMARY 54
FIGURE 11 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 54
FIGURE 12 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 55
FIGURE 13 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 55
FIGURE 14 IN VITRO DIAGNOSTICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 56
FIGURE 15 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 57
4 PREMIUM INSIGHTS 58
4.1 IN VITRO DIAGNOSTICS MARKET OVERVIEW 58
FIGURE 16 RISING INCIDENCE OF CHRONIC & INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE IN VITRO DIAGNOSTICS MARKET 58
4.2 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT &
SERVICE AND COUNTRY (2019) 59
4.3 IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 17 THE MARKET IN CHINA IS PROJECTED TO REGISTER THE HIGHEST CAGR IN THE IN VITRO DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 60
4.4 GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET 61
FIGURE 18 APAC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 61
4.5 IN VITRO DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 61
FIGURE 19 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 20 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.2.1 DRIVERS 63
5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 63
TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION
(2019–2050) 63
5.2.1.2 Increasing adoption of fully automated and POC instruments in developed regions 64
5.2.1.3 Growing awareness regarding disease diagnosis in developing regions 64
5.2.1.4 Growing R&D investments by industry players to launch new IVD products 65
5.2.2 RESTRAINTS 65
5.2.2.1 Unfavorable reimbursement scenario 65
5.2.3 OPPORTUNITIES 65
5.2.3.1 Development of condition-specific markers and tests 65
TABLE 3 NEW TESTS LAUNCHED BY KEY PLAYERS 66
5.2.3.2 Growing significance of companion diagnostics 66
5.2.3.3 Growth opportunities in emerging countries 67
5.2.4 CHALLENGES 67
5.2.4.1 Changing regulatory landscape 67
5.2.4.2 Operational barriers faced in conducting diagnostic tests 67
5.2.5 IMPACT OF COVID-19 ON THE IVD MARKET 68
6 INDUSTRY INSIGHTS 70
6.1 INTRODUCTION 70
6.2 PORTER’S FIVE FORCES ANALYTICAL FRAMEWORK 70
6.3 PESTLE ANALYSIS 71
6.4 INDUSTRY ECOSYSTEM ANALYSIS 72
6.5 INDUSTRY TRENDS 72
6.5.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES 72
6.5.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING 73
6.5.3 GROWING NUMBER OF REAGENT RENTAL AGREEMENTS 73
6.6 REGULATORY OVERVIEW 74
6.6.1 US 74
TABLE 4 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 74
FIGURE 21 US: REGULATORY PROCESS FOR IVD DEVICES 75
6.6.2 CANADA 76
FIGURE 22 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA 76
6.6.3 EUROPE 77
TABLE 5 EUROPE: CLASSIFICATION OF IVD DEVICES 77
FIGURE 23 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 78
6.6.4 JAPAN 79
FIGURE 24 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN 79
TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS CLASSIFICATION OF IVD REAGENTS IN JAPAN 80
TABLE 7 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80
6.6.5 CHINA 80
TABLE 8 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80
6.6.6 INDIA 81
FIGURE 25 INDIA: REGULATORY PROCESS FOR IVD DEVICES 81
6.6.7 INDONESIA 82
TABLE 9 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES 82
6.6.8 RUSSIA 83
TABLE 10 RUSSIA: CLASSIFICATION OF IVD DEVICES 83
6.6.9 SAUDI ARABIA 83
TABLE 11 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 83
6.6.10 MEXICO 84
FIGURE 26 MEXICO: REGULATORY PROCESS FOR IVD DEVICES 84
TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 84
6.6.11 BRAZIL 85
FIGURE 27 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES 85
6.6.12 SOUTH KOREA 86
TABLE 13 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 86
6.7 VENDOR BENCHMARKING 86
TABLE 14 IN VITRO DIAGNOSTIC PRODUCTS & SERVICES MARKET: PRODUCT PORTFOLIO ANALYSIS 86
7 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 88
7.1 INTRODUCTION 89
TABLE 15 IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 89
7.2 REAGENTS & KITS 89
TABLE 16 IVD REAGENTS & KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 90
TABLE 17 IVD REAGENTS & KITS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 91
7.3 INSTRUMENTS 91
TABLE 18 IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 19 IVD INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
TABLE 20 IVD INSTRUMENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 93
7.3.1 SEMI-AUTOMATED INSTRUMENTS 93
TABLE 21 SEMI-AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 94
7.3.2 FULLY AUTOMATED INSTRUMENTS 94
TABLE 22 MAJOR LAB AUTOMATION SYSTEMS & FULLY AUTOMATED INSTRUMENTS IN THE MARKET 95
TABLE 23 FULLY AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 96
7.3.3 OTHER INSTRUMENTS 96
TABLE 24 OTHER IVD INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 97
7.4 SERVICES 97
FIGURE 28 TYPES OF IN VITRO DIAGNOSTIC SERVICES 98
TABLE 25 IVD SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 98
TABLE 26 IVD SERVICES MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 99
7.5 DATA MANAGEMENT SOFTWARE 99
TABLE 27 KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN THE MARKET 100
TABLE 28 IVD DATA MANAGEMENT SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 29 IVD DATA MANAGEMENT SOFTWARE MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 101
8 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 102
8.1 INTRODUCTION 103
TABLE 30 IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 103
8.2 IMMUNOASSAY/IMMUNOCHEMISTRY 103
TABLE 31 IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE
IN THE MARKET 104
TABLE 32 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 33 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 106
8.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAYS 106
TABLE 34 ELISA ANALYZERS AVAILABLE IN THE MARKET 107
TABLE 35 ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 108
TABLE 36 ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
8.2.1.1 Chemiluminescence immunoassays 109
TABLE 37 CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN THE MARKET 109
TABLE 38 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 110
8.2.1.2 Fluorescence immunoassays 110
TABLE 39 FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 111
8.2.1.3 Colorimetric immunoassays 111
TABLE 40 COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 112
8.2.2 RADIOIMMUNOASSAYS 112
TABLE 41 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 113
8.2.3 RAPID TESTS 113
TABLE 42 RAPID TESTS AVAILABLE IN THE MARKET 114
TABLE 43 RAPID TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 115
8.2.4 WESTERN BLOTTING 115
TABLE 44 WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET 116
TABLE 45 WESTERN BLOTTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 116
8.2.5 ENZYME-LINKED IMMUNOSPOT ASSAYS 117
TABLE 46 ELISPOT ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 117
8.3 CLINICAL CHEMISTRY 118
TABLE 47 CLINICAL CHEMISTRY ANALYZERS FOR HIGH- AND MID-
VOLUME LABORATORIES 118
TABLE 48 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES 120
TABLE 49 BLOOD GAS ANALYZERS AVAILABLE IN THE MARKET 121
TABLE 50 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 122
TABLE 51 CLINICAL CHEMISTRY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION) 122
8.3.1 BASIC METABOLIC PANELS 123
TABLE 52 BASIC METABOLIC PANELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 123
8.3.2 LIVER PANELS 124
TABLE 53 LIVER PANELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 124
8.3.3 RENAL PROFILES 125
TABLE 54 RENAL PROFILES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 125
8.3.4 LIPID PROFILES 126
TABLE 55 LIPID PROFILES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 126
8.3.5 THYROID FUNCTION PANELS 127
TABLE 56 THYROID FUNCTION PANELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 127
8.3.6 ELECTROLYTE PANELS 127
TABLE 57 ELECTROLYTE PANELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 128
8.3.7 SPECIALTY CHEMICAL TESTS 128
TABLE 58 SPECIALTY CHEMICAL TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 129
8.4 MOLECULAR DIAGNOSTICS 129
TABLE 59 AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE
IN THE MARKET 130
TABLE 60 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 131
TABLE 61 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 132
8.4.1 POLYMERASE CHAIN REACTION 132
TABLE 62 PCR INSTRUMENTS AVAILABLE IN THE MARKET 133
TABLE 63 POLYMERASE CHAIN REACTION MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 134
8.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY 134
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 135
8.4.3 HYBRIDIZATION 135
TABLE 65 HYBRIDIZATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 136
8.4.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING 136
TABLE 66 NGS INSTRUMENTS AVAILABLE IN THE MARKET 137
TABLE 67 DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 138
8.4.5 MICROARRAYS 138
TABLE 68 MICROARRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 139
8.4.6 OTHER MDX TECHNOLOGIES 140
TABLE 69 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 140
8.5 HEMATOLOGY 141
TABLE 70 HEMATOLOGY ANALYZERS AVAILABLE IN THE MARKET 141
TABLE 71 HEMATOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 143
8.6 MICROBIOLOGY 143
TABLE 72 MICROBIOLOGY INSTRUMENTS AVAILABLE IN THE MARKET 144
TABLE 73 MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 145
8.7 COAGULATION & HEMOSTASIS 146
TABLE 74 COAGULATION ANALYZERS AVAILABLE IN THE MARKET 146
TABLE 75 POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS AVAILABLE IN THE MARKET 148
TABLE 76 COAGULATION & HEMOSTASIS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 148
8.8 URINALYSIS 149
TABLE 77 URINALYSIS INSTRUMENTS AVAILABLE IN THE MARKET 149
TABLE 78 URINALYSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 150
8.9 OTHER TECHNOLOGIES 150
TABLE 79 BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN THE MARKET 151
TABLE 80 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS AVAILABLE IN THE MARKET 151
TABLE 81 OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 153
9 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 154
9.1 INTRODUCTION 155
TABLE 82 IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 155
9.2 INFECTIOUS DISEASES 155
TABLE 83 IVD MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,
2018–2025 (USD MILLION) 156
9.3 DIABETES 156
TABLE 84 GLOBAL DIABETIC PATIENT POPULATION, 2019 VS. 2030 (MILLION) 157
TABLE 85 IVD MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD MILLION) 158
9.4 ONCOLOGY 158
TABLE 86 IVD MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 159
9.5 CARDIOLOGY 160
TABLE 87 IVD MARKET FOR CARDIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 160
9.6 DRUG TESTING/PHARMACOGENOMICS 161
TABLE 88 IVD MARKET FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY, 2018–2025 (USD MILLION) 161
9.7 HIV/AIDS 162
TABLE 89 IVD MARKET FOR HIV/AIDS, BY COUNTRY, 2018–2025 (USD MILLION) 162
9.8 AUTOIMMUNE DISEASES 163
TABLE 90 IVD MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY,
2018–2025 (USD MILLION) 164
9.9 NEPHROLOGY 164
TABLE 91 IVD MARKET FOR NEPHROLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 165
9.10 OTHER APPLICATIONS 165
TABLE 92 IVD MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2018–2025 (USD MILLION) 166
10 IN VITRO DIAGNOSTICS MARKET, BY END USER 167
10.1 INTRODUCTION 168
TABLE 93 IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 168
10.2 HOSPITAL LABORATORIES 168
TABLE 94 IVD MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY,
2018–2025 (USD MILLION) 169

10.3 CLINICAL LABORATORIES 169
TABLE 95 IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 170
TABLE 96 IVD MARKET FOR CLINICAL LABORATORIES, BY COUNTRY,
2018–2025 (USD MILLION) 170
10.3.1 LARGE/REFERENCE LABORATORIES 171
TABLE 97 LARGE/REFERENCE LABORATORIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 171
10.3.2 MEDIUM-SIZED LABORATORIES 172
TABLE 98 MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 172
10.3.3 SMALL LABORATORIES 172
TABLE 99 SMALL LABORATORIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 173
10.4 POINT-OF-CARE TESTING 173
TABLE 100 IVD MARKET FOR POC TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 174
10.5 PATIENT SELF-TESTING 174
TABLE 101 IVD MARKET FOR PATIENT SELF-TESTING, BY COUNTRY,
2018–2025 (USD MILLION) 175
10.6 ACADEMIC INSTITUTES 175
TABLE 102 IVD MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY,
2018–2025 (USD MILLION) 176
10.7 OTHER END USERS 176
TABLE 103 IVD MARKET FOR OTHER END USERS, BY COUNTRY,
2018–2025 (USD MILLION) 177
11 IN VITRO DIAGNOSTICS MARKET, BY REGION 178
11.1 INTRODUCTION 179
TABLE 104 IVD MARKET, BY REGION, 2018–2025 (USD MILLION) 179
11.2 NORTH AMERICA 179
FIGURE 29 NORTH AMERICA: IVD MARKET SNAPSHOT 180
TABLE 105 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 180
TABLE 106 NORTH AMERICA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 181
TABLE 107 NORTH AMERICA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 181
TABLE 108 NORTH AMERICA: IVD MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 181
TABLE 109 NORTH AMERICA: IVD MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 182
TABLE 110 NORTH AMERICA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 182
TABLE 111 NORTH AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2018–2025 (USD MILLION) 182
11.2.1 US 183
TABLE 112 US: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 183
TABLE 113 US: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 183
TABLE 114 US: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 184
TABLE 115 US: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 184
TABLE 116 US: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 185
TABLE 117 US: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 185
11.2.2 CANADA 185
TABLE 118 CANADA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 186
TABLE 119 CANADA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 186
TABLE 120 CANADA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 186
TABLE 121 CANADA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 187
TABLE 122 CANADA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 187
TABLE 123 CANADA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 187
11.3 EUROPE 188
FIGURE 30 EUROPE: IVD MARKET SNAPSHOT 188
TABLE 124 EUROPE: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 189
TABLE 125 EUROPE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 189
TABLE 126 EUROPE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 189
TABLE 127 EUROPE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 190
TABLE 128 EUROPE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 190
TABLE 129 EUROPE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 191
TABLE 130 EUROPE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 191
11.3.1 GERMANY 191
TABLE 131 GERMANY: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 192
TABLE 132 GERMANY: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 192
TABLE 133 GERMANY: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 192
TABLE 134 GERMANY: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 193
TABLE 135 GERMANY: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 193
TABLE 136 GERMANY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 193
11.3.2 FRANCE 194
TABLE 137 FRANCE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 194
TABLE 138 FRANCE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 194
TABLE 139 FRANCE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 195
TABLE 140 FRANCE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 195
TABLE 141 FRANCE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 196
TABLE 142 FRANCE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 196
11.3.3 UK 196
TABLE 143 UK: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 197
TABLE 144 UK: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 197
TABLE 145 UK: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 197
TABLE 146 UK: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 198
TABLE 147 UK: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 198
TABLE 148 UK: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 198
11.3.4 ITALY 199
TABLE 149 ITALY: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 199
TABLE 150 ITALY: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 199
TABLE 151 ITALY: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 199
TABLE 152 ITALY: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 200
TABLE 153 ITALY: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 200
TABLE 154 ITALY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 200
11.3.5 SPAIN 201
TABLE 155 SPAIN: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 201
TABLE 156 SPAIN: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 201
TABLE 157 SPAIN: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 202
TABLE 158 SPAIN: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 202
TABLE 159 SPAIN: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 203
TABLE 160 SPAIN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 203
11.3.6 RUSSIA 203
TABLE 161 RUSSIA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 204
TABLE 162 RUSSIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 204
TABLE 163 RUSSIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 204
TABLE 164 RUSSIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 205
TABLE 165 RUSSIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 205
TABLE 166 RUSSIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 205
11.3.7 REST OF EUROPE 206
TABLE 167 ROE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 206
TABLE 168 ROE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 206
TABLE 169 ROE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 207
TABLE 170 ROE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 207
TABLE 171 ROE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 208
TABLE 172 ROE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 208
11.4 ASIA PACIFIC 208
FIGURE 31 ASIA PACIFIC: IVD MARKET SNAPSHOT 209
TABLE 173 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 209
TABLE 174 ASIA PACIFIC: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 210
TABLE 175 ASIA PACIFIC: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 210
TABLE 176 ASIA PACIFIC: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 210
TABLE 177 ASIA PACIFIC: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 211
TABLE 178 ASIA PACIFIC: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 211
TABLE 179 ASIA PACIFIC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 211
11.4.1 JAPAN 212
TABLE 180 JAPAN: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 212
TABLE 181 JAPAN: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 212
TABLE 182 JAPAN: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 213
TABLE 183 JAPAN: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 213
TABLE 184 JAPAN: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 214
TABLE 185 JAPAN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 214
11.4.2 CHINA 214
TABLE 186 CHINA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 215
TABLE 187 CHINA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 215
TABLE 188 CHINA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 215
TABLE 189 CHINA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 216
TABLE 190 CHINA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 216
TABLE 191 CHINA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 216
11.4.3 INDIA 217
TABLE 192 INDIA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 217
TABLE 193 INDIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 218
TABLE 194 INDIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 218
TABLE 195 INDIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 218
TABLE 196 INDIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 219
TABLE 197 INDIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 219
11.4.4 SOUTH KOREA 219
TABLE 198 SOUTH KOREA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 220
TABLE 199 SOUTH KOREA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 220
TABLE 200 SOUTH KOREA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 220
TABLE 201 SOUTH KOREA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 221
TABLE 202 SOUTH KOREA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 221
TABLE 203 SOUTH KOREA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 221
11.4.5 INDONESIA 222
TABLE 204 INDONESIA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 222
TABLE 205 INDONESIA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 222
TABLE 206 INDONESIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 223
TABLE 207 INDONESIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 223
TABLE 208 INDONESIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 224
TABLE 209 INDONESIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 224
11.4.6 REST OF ASIA PACIFIC 224
TABLE 210 ROAPAC: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 224
TABLE 211 ROAPAC: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 225
TABLE 212 ROAPAC: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 225
TABLE 213 ROAPAC: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 225
TABLE 214 ROAPAC: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 226
TABLE 215 ROAPAC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 226
11.5 LATIN AMERICA 226
TABLE 216 LATIN AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 227
TABLE 217 LATIN AMERICA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 227
TABLE 218 LATIN AMERICA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 227
TABLE 219 LATIN AMERICA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 228
TABLE 220 LATIN AMERICA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 228
TABLE 221 LATIN AMERICA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 229
TABLE 222 LATIN AMERICA: IVD MARKET FOR CLINICAL LABORATORIES,
BY TYPE, 2018–2025 (USD MILLION) 229
11.5.1 BRAZIL 229
TABLE 223 BRAZIL: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 230
TABLE 224 BRAZIL: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 230
TABLE 225 BRAZIL: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 230
TABLE 226 BRAZIL: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 231
TABLE 227 BRAZIL: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 231
TABLE 228 BRAZIL: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 231
11.5.2 MEXICO 232
TABLE 229 MEXICO: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 232
TABLE 230 MEXICO: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 232
TABLE 231 MEXICO: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 233
TABLE 232 MEXICO: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 233
TABLE 233 MEXICO: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 234
TABLE 234 MEXICO: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 234
11.5.3 REST OF LATIN AMERICA 234
TABLE 235 ROLA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 234
TABLE 236 ROLA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 235
TABLE 237 ROLA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 235
TABLE 238 ROLA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 235
TABLE 239 ROLA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 236
TABLE 240 ROLA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 236
11.6 MIDDLE EAST & AFRICA 236
TABLE 241 MIDDLE EAST & AFRICA: IVD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 236
TABLE 242 MIDDLE EAST & AFRICA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 237
TABLE 243 MIDDLE EAST & AFRICA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 237
TABLE 244 MIDDLE EAST & AFRICA: IVD MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 237
TABLE 245 MIDDLE EAST & AFRICA: IVD MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 238
TABLE 246 MIDDLE EAST & AFRICA: IVD MARKET, BY END USER,
2018–2025 (USD MILLION) 238
TABLE 247 MIDDLE EAST & AFRICA: IVD MARKET FOR CLINICAL LABORATORIES,
BY TYPE, 2018–2025 (USD MILLION) 238
11.6.1 SAUDI ARABIA 239
TABLE 248 SAUDI ARABIA: IVD MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 239
TABLE 249 SAUDI ARABIA: IVD INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 239
TABLE 250 SAUDI ARABIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 240
TABLE 251 SAUDI ARABIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 240
TABLE 252 SAUDI ARABIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 241
11.6.2 REST OF MIDDLE EAST & AFRICA (ROMEA) 241
TABLE 253 ROMEA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 241
TABLE 254 ROMEA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 241
TABLE 255 ROMEA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 242
TABLE 256 ROMEA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 242
TABLE 257 ROMEA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 243
TABLE 258 ROMEA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,
2018–2025 (USD MILLION) 243
12 COMPETITIVE LANDSCAPE 244
12.1 INTRODUCTION 244
FIGURE 32 KEY DEVELOPMENTS IN THE IVD MARKET 244
12.2 COMPETITIVE EVALUATION MATRIX 245
12.2.1 STARS 245
12.2.2 EMERGING LEADERS 245
12.2.3 PERVASIVE PLAYERS 245
12.2.4 PARTICIPANTS 245
FIGURE 33 IVD MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 246

12.3 MARKET SHARE ANALYSIS 246
FIGURE 34 GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYER (2019) 247
12.3.1 MARKET SHARE ANALYSIS, BY TECHNOLOGY 248
12.3.1.1 Clinical chemistry 248
FIGURE 35 GLOBAL CLINICAL CHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 248
12.3.1.2 Immunochemistry/immunoassay analyzers 248
FIGURE 36 GLOBAL IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 249
12.3.1.3 Clinical microbiology systems 249
FIGURE 37 GLOBAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 249
12.3.1.4 Molecular diagnostics 250
FIGURE 38 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYER (2019) 250
12.3.1.5 Hematology 250
FIGURE 39 GLOBAL HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 251
12.3.1.6 Clinical coagulation analyzers 251
FIGURE 40 GLOBAL CLINICAL COAGULATION ANALYZERS MARKET SHARE ANALYSIS,
BY KEY PLAYER (2019) 251
12.4 COMPETITIVE SITUATION AND TRENDS 252
12.4.1 PRODUCT LAUNCHES & APPROVALS 252
TABLE 259 PRODUCT LAUNCHES & APPROVALS 252
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 252
TABLE 260 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 253
12.4.3 ACQUISITIONS 253
TABLE 261 ACQUISITIONS 253
12.4.4 EXPANSIONS 254
TABLE 262 EXPANSIONS 254
13 COMPANY PROFILES 255
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 ROCHE DIAGNOSTICS 255
FIGURE 41 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019) 255
13.2 DANAHER CORPORATION 262
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 262
13.3 ABBOTT LABORATORIES, INC. 272
FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 272
13.4 SIEMENS HEALTHINEERS 279
FIGURE 44 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019) 279
13.5 SYSMEX CORPORATION 286
FIGURE 45 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019) 286
13.6 THERMO FISHER SCIENTIFIC 291
FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016) 291
13.7 BECTON, DICKINSON AND COMPANY 302
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 302
13.8 BIOMÉRIEUX SA 307
FIGURE 48 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2019) 307
13.9 BIO-RAD LABORATORIES, INC. 312
FIGURE 49 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 312
13.10 JOHNSON & JOHNSON 318
FIGURE 50 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019) 318
13.11 AGILENT TECHNOLOGIES 320
FIGURE 51 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 320
13.12 QIAGEN 325
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2019) 325
13.13 DIASORIN 331
FIGURE 53 DIASORIN: COMPANY SNAPSHOT (2019) 331
13.14 ORTHO CLINICAL DIAGNOSTICS (A PART OF CARLYLE GROUP) 341
13.15 SPEEDX DIAGNOSTICS 343
13.16 GENSPEED BIOTECH GMBH 344
13.17 GENOMEME 345
13.18 ACCELERATE DIAGNOSTICS, INC. 346
13.19 MSDX 347
13.20 CARIS LIFE SCIENCES, INC. 347
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 348
14.1 DISCUSSION GUIDE 349
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 355
14.3 AVAILABLE CUSTOMIZATIONS 357
14.4 RELATED REPORTS 358
14.5 AUTHOR DETAILS 359



★調査レポート[体外診断用医薬品(IVD)の世界市場予測(~2025):製品・サービス別、技術別、用途別、エンドユーザー別] ( In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 / MD 3609) 販売に関する免責事項
[体外診断用医薬品(IVD)の世界市場予測(~2025):製品・サービス別、技術別、用途別、エンドユーザー別] ( In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 / MD 3609) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆